Featuring: Isabella Chow, PharmD Candidate c/o 2024By: Isabelle Lim, PharmD Candidate c/o 2024 Isabella Chow is a sixth-year pharmacy student at St. John’s University. She was involved in various organizations on campus, including PLS, Rho Chi, LKS, Crafts Club, and VSA. She held leadership positions in multiple pharmacy organizations, including IPhO Director of Communications, DIA…

Congratulations to the sixth-year pharmacy students for graduating and to the rest of the student body for completing another year of pharmacy school! I am humbled and honored to announce my new position as the Editor-in-Chief of the Rho Chi Post for the upcoming year. It is with the continued dedication of the Editorial Team…

By: Nancy Yousry, PharmD Candidate c/o 2024 Delirium is characterized as impaired cognition with a wide range of manifestations that are nonspecific to the state, making it harder to detect in its earlier stages.1 Inadequate management has frequently resulted from a failure to recognize the condition. Elderly patients are most often susceptible to delirium when…

By: Ashley Dao, PharmD Candidate c/o 2024 Medical abortion is approved by the Food and Drug Administration (FDA) to end intrauterine pregnancy through ten weeks gestation (i.e., within 70 days of the start of a patient’s last menstrual period). Mifepristone plays a major role in the termination of early pregnancies within the United States (U.S.).…

By: Geraldine Ciaccio, PharmD Candidate c/o 2025 ​The role of pharmacists in public health has been expanding in recent years. The list of pharmacists’ responsibilities continues to grow with the treatment of the opioid crisis in the United States. In the past year, pharmacists newly received the authority to dispense naloxone under a standing order.…

Featuring: Krishna Tamakuwala, PharmDBy: Justin Budz, PharmD Krishna Tamakuwala is a recent graduate from the St. John’s University Doctor of Pharmacy program, class of 2023. Krishna always knew she wanted to go into the medical field. Besides her passion for the sciences, Krishna also enjoyed cooking. She found it interesting how certain aspects of pharmacy…

By: Urooj K. Malik, PharmD Candidate c/o 2024 March 1, 2023 marked a substantial milestone in the United States’ (U.S.’) fight for affordable insulin. Eli Lilly and Company (Lilly) has announced that over the next few months, they will be reducing the price of multiple insulin products as well as capping patient out-of-pocket costs at…

By: Samia Rahman Adity, PharmD Candidate c/o 2025               Migraine has been a throbbing topic of discussion and a serious public health concern in the United States (U.S.). As of 2018, headache was seen to be the fourth or fifth most common cause for patients to visit an emergency department.1 The National Institute of Neurological…